Senator Disclosure: Social media chatter centers on a recent filing revealing a senator's purchase of ARCC shares near $19.97. The stock has traded modestly lower since, drawing scrutiny to the move amid broader market conditions.
Dividend Emphasis: Participants stress the business development company's appeal through its roughly 9 to 10 percent yield and stable payout history. Many note that returns derive primarily from income rather than price appreciation in this structure.
Portfolio Insights: Conversations examine credit quality and deployment activity as central to the company's outlook. Some observers see the recent price dip relative to the disclosed entry as noteworthy in context of the senator's overall performance.
Note: This discussion summary was generated from an AI condensation of post data.
Ares Capital Revenue
Ares Capital had revenues of $768M in Q2 2026. This is an increase of 3.09% from the same period in the prior year.
You can track ARCC financials on Quiver Quantitative's ARCC stock page.
You can access data on ARCC stock through the Quiver Quantitative API.
Ares Capital Congressional Stock Trading
Members of Congress have traded $ARCC stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $ARCC stock by members of Congress over the last 6 months:
- REPRESENTATIVE PETE SESSIONS sold up to $15,000 on 07/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
Ares Capital Hedge Fund Activity
We have seen 373 institutional investors add shares of Ares Capital stock to their portfolio, and 442 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO added 7,850,659 shares (+inf%) to their portfolio in Q2 2026, for an estimated $145,472,711
- CITADEL ADVISORS LLC removed 5,159,501 shares (-63.9%) from their portfolio in Q1 2026, for an estimated $92,096,576
- VAN ECK ASSOCIATES CORP added 2,418,984 shares (+22.2%) to their portfolio in Q2 2026, for an estimated $44,823,773
- CLEARBRIDGE INVESTMENTS, LLC removed 1,644,729 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $29,358,248
- TWO SIGMA INVESTMENTS, LP removed 1,420,322 shares (-19.4%) from their portfolio in Q2 2026, for an estimated $26,318,566
- HIGHTOWER ADVISORS, LLC added 1,087,875 shares (+44.5%) to their portfolio in Q1 2026, for an estimated $19,418,459
- TREXQUANT INVESTMENT LP removed 990,711 shares (-95.6%) from their portfolio in Q2 2026, for an estimated $18,357,874
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Ares Capital Price Targets
Multiple analysts have issued price targets for $ARCC recently. We have seen 6 analysts offer price targets for $ARCC in the last 6 months, with a median target of $21.0.
Here are some recent targets:
- Richard Shane from JP Morgan set a target price of $18.5 on 07/02/2026
- Finian O'Shea from Wells Fargo set a target price of $19.0 on 06/12/2026
- Arren Cyganovich from Truist Securities set a target price of $22.0 on 04/29/2026
- Kenneth S. Lee from RBC Capital set a target price of $21.0 on 04/29/2026
- Brian McKenna from Citizens set a target price of $22.0 on 04/22/2026
- Paul Johnson from Keefe, Bruyette & Woods set a target price of $21.0 on 04/16/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
